Uveitis

  • Ozurdex 2021 report

    Ozurdex 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 17 Pages The 5 Key Questions Addressed by this Report:...

  • Yutiq 2021 report

    Yutiq 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 17 Pages The 5 Key Questions Addressed by this Report:...

  • Eliquis 2020 report

    Eliquis 2020 U.S. PROMOTIONAL AUDIT REPORT Published July 2021 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Pediarix 2020 report

    Pediarix 2020 U.S. PROMOTIONAL AUDIT REPORT Published July 2021 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Zemaira 2020 report

    Zemaira 2020 U.S. PROMOTIONAL AUDIT REPORT Published July 2021 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Durezol 2019 report

    Durezol 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 19 Pages The 5 Key Questions Addressed by this Report:...

  • Ozurdex 2019 report

    Ozurdex 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Yutiq 2019 report

    Yutiq 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 19 Pages The 5 Key Questions Addressed by this Report:...

  • Durezol 2018 report

    Durezol 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 19 Pages The 5 Key Questions Addressed by this Report:...

  • Ozurdex 2018 report

    Ozurdex 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 19 Pages The 5 Key Questions Addressed by this Report:...

  • Durezol 2017 report

    Durezol 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Ozurdex 2017 report

    Ozurdex 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 19 Pages The 5 Key Questions Addressed by this Report:...